![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Arylsulfatase A Deficiency - GeneReviews® - NCBI Bookshelf
2006年5月30日 · Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile, juvenile, and adult MLD. The age of onset within a family is usually similar. The disease course may be from several years in the late-infantile-onset form to decades in the juvenile- and adult-onset forms.
Arylsulfatase A, Leukocytes - Mayo Clinic Laboratories | Neurology Catalog
Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder caused by a deficiency of the enzyme arylsulfatase A (ARSA), which leads to the accumulation of sulfatides (both galactosyl and lactosyl sulfatide) in the white matter of the central nervous system, the peripheral nervous system, and, to a lesser extent, in visceral organs ...
Arylsulfatase A Deficiency - PubMed
2024年4月25日 · Clinical characteristics: Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile, juvenile, and adult MLD. The age of onset within a family is usually similar.
ARSAW - Overview: Arylsulfatase A, Leukocytes - Mayo Clinic …
Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder caused by a deficiency of the enzyme arylsulfatase A (ARSA), which leads to the accumulation of sulfatides (both galactosyl and lactosyl sulfatide) in the white matter of the central nervous system, the peripheral nervous system, and, to a lesser extent, in visceral organs ...
Pseudoarylsulfatase A deficiency - NIH Genetic Testing Registry …
Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile MLD, juvenile MLD, and adult MLD. Age of onset within a family is usually similar. The disease course may be from several years in the late-infantile-onset form to decades in the juvenile- and adult-onset forms.
Pseudoarylsulfatase A deficiency (Concept Id: C1855255)
Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile MLD, juvenile MLD, and adult MLD. Age of onset within a family is usually similar.
Arylsulfatase A - an overview | ScienceDirect Topics
Arylsulfatase A or cerebroside sulfatase is a lysosomal acid hydrolase, and its physiological substrate, 3-sulfo-galactosylceramide, was discovered during elucidation of the enzyme deficiency responsible for sulfatidosis, metachromatic leukodystrophy [260,455,485].
Lysosomal arylsulfatase deficiencies in humans: Chromosome ... - PNAS
Deficiency of arylsulfatase B (ARS B) is associated with skeletal and growth malformations, termed the Maroteaux-Lamy syndrome. Simultaneous deficiency of both enzymes is associated with the multiple sulfatase deficiency disease, suggesting a common relationship for ARS A …
Diagnosis of arylsulfatase A deficiency - PubMed
1992年8月1日 · Metachromatic leukodystrophy (MLD) is a neurologically devastating autosomal recessive disorder in humans associated with deficient arylsulfatase A activity. However, clinically normal individuals described as being pseudo-arylsulfatase-A deficient also demonstrate the same deficiency.
Arylsulfatase A Deficiency - Abstract - Europe PMC
Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile MLD, juvenile MLD, and adult MLD. Age of onset within a family is usually similar.